Mucosa-associated microbiota dysbiosis in colitis associated cancer

Gut Microbes

Volumn 9, Issue 2, 2018, Pages 131-142

  Richard, Mathias L ^a,b   Liguori, Giuseppina ^c   Lamas, Bruno ^b,d   Brandi, Giovanni ^c   da Costa, Gregory ^a,b   Hoffmann, Thomas W ^a,b   Pierluigi Di Simone, Massimo ^c   Calabrese, Carlo ^c   Poggioli, Gilberto ^c   Langella, Philippe ^a,b   Campieri, Massimo ^c   Sokol, Harry ^a,b,d,e  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Inflammation Immunopathology Biotherapy Department (DHU i2B)   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Centre National de la Recherche Scientifique   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Cancer; dysbiosis; fungal microbiota; Inflammatory bowel disease; mucosa associated microbiota

Indexed keywords

ACTINOBACTERIA; ADULT; AGED; ARTICLE; ASCOMYCETES; BACTEROIDETES; BASIDIOMYCETES; CANCER PATIENT; CLINICAL ARTICLE; COLITIS ASSOCIATED CANCER; CONTROLLED STUDY; DYSBIOSIS; ENTEROBACTERIACEAE; FEMALE; FIRMICUTES; FUNGAL COMMUNITY; FUSOBACTERIA; FUSOBACTERIUM; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE CANCER; INTESTINE FLORA; INTESTINE MUCOSA; MALE; NONHUMAN; PRINCIPAL COORDINATE ANALYSIS; PROTEOBACTERIA; PYROSEQUENCING; RUMINOCOCCUS; SEQUENCE ANALYSIS; SPHINGOMONAS; BACTERIUM; BIODIVERSITY; CLASSIFICATION; COHORT ANALYSIS; COLITIS; COLORECTAL TUMOR; COMPLICATION; CROHN DISEASE; FUNGUS; GENETICS; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; ULCERATIVE COLITIS; VERY ELDERLY;

RIBOSOMAL SPACER DNA; RNA 16S;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BIODIVERSITY; COHORT STUDIES; COLITIS; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; DNA, RIBOSOMAL SPACER; DYSBIOSIS; FEMALE; FUNGI; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RNA, RIBOSOMAL, 16S;

EID: 85031413735     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2017.1379637     Document Type: Article

References (33)

1. Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res: An official journal of the American Association for Cancer Research. 2014;20:859-867. doi:10.1158/1078-0432.CCR-13-1343. PMID:24334760
2. Brennan CA, Garrett WS. Gut Microbiota, Inflammation, and Colorectal Cancer. Annu Rev Microbiol. 2016;70:395-411. doi:10.1146/annurev-micro-102215-095513. PMID:27607555
3. Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer epidemiology, biomarkers & prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008;17:2970-2979. doi:10.1158/1055-9965.EPI-08-0571.
4. Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol. 2015;6:20. doi:10.3389/fmicb.2015.00020. PMID:25699023
5. Konstantinov SR, Kuipers EJ, Peppelenbosch MP. Functional genomic analyses of the gut microbiota for CRC screening. Nature Reviews Gastroenterology & Hepatology. 2013;10:741-745. doi:10.1038/nrgastro.2013.178.
6. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207-215. doi:10.1016/j.chom.2013.07.007. PMID:23954159
7. Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, et al. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol. 2016;7:e200. doi:10.1038/ctg.2016.53. PMID:27811909
8. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:766. doi:10.15252/msb.20145645. PMID:25432777
9. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nature reviews Gastroenterology & hepatology. 2012;9:599-608. doi:10.1038/nrgastro.2012.152.
10. Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013;16:255-261. doi:10.1016/j.mib.2013.06.003. PMID:23831042
11. Liguori G, Lamas B, Richard ML, Brandi G, da Costa G, Hoffmann TW, Di Simone MP, Calabrese C, Poggioli G, Langella P, et al. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients. J Crohns Colitis. 2016;10:296-305. doi:10.1093/ecco-jcc/jjv209. PMID:26574491
12. Lepage P, Seksik P, Sutren M, de la Cochetière MF, Jian R, Marteau P, Doré J. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis. 2005;11:473-480. doi:10.1097/01.MIB.0000159662.62651.06. PMID:15867587
13. McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagacé C, Li C, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010;42:332-337. doi:10.1038/ng.549. PMID:20228799
14. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Met. 2010;7:335-336. doi:10.1038/nmeth.f.303.
15. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460-2461. doi:10.1093/bioinformatics/btq461. PMID:20709691
16. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610-618. doi:10.1038/ismej.2011.139. PMID:22134646
17. Kõljalg U, Nilsson RH, Abarenkov K, Tedersoo L, Taylor AF, Bahram M, Bates ST, Bruns TD, Bengtsson-Palme J, Callaghan TM, et al. Towards a unified paradigm for sequence-based identification of fungi. Mol Ecol. 2013;22:5271-5277. doi:10.1111/mec.12481. PMID:24112409
18. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. doi:10.1186/gb-2011-12-6-r60. PMID:21702898
19. Morgan XC, Huttenhower C. Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology. 2014;146:1437-1448 e1431. doi:10.1053/j.gastro.2014.01.049. PMID:24486053
20. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology. 1995;108:1396-1404. doi:10.1016/0016-5085(95)90687-8. PMID:7729631
21. Munro J, Mayberry JF, Matthews N, Rhodes J. Chlamydia and Crohn's disease. Lancet. 1979;2:45-46. doi:10.1016/S0140-6736(79)90213-7. PMID:87925
22. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93. doi:10.1053/j.gastro.2004.03.054. PMID:15236175
23. Subramanian S, Rhodes JM, Hart CA, Tam B, Roberts CL, Smith SL, Corkill JE, Winstanley C, Virji M, Campbell BJ. Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm Bowel Dis. 2008;14:162-175. doi:10.1002/ibd.20296. PMID:17941093
24. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489:231-241. doi:10.1038/nature11551. PMID:22972296
25. Sokol H, et al. Fungal microbiota dysbiosis in IBD. Gut. 2016. doi:10.1136/gutjnl-2015-310746.
26. Baxter NT, Ruffin MTT, Rogers MA, Schloss PD. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med. 2016;8:37. doi:10.1186/s13073-016-0290-3. PMID:27056827
27. Thomas AM, Jesus EC, Lopes A, Aguiar S, Jr, Begnami MD, Rocha RM, Carpinetti PA, Camargo AA, Hoffmann C, Freitas HC, et al. Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling. Front Cell Infect Microbiol. 2016;6:1-13. doi:10.3389/fcimb.2016.00179. PMID:26870699
28. Abdulamir AS, Hafidh RR, Abu Bakar F. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res: CR 2011;30:11. doi:10.1186/1756-9966-30-11.
29. Sun J, Kato I. Gut microbiota, inflammation and colorectal cancer. Genes & Diseases 2016;3:130-143. doi:10.1016/j.gendis.2016.03.004.
30. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-1189. doi:10.1002/ibd.20903. PMID:19235886
31. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PloS one 2012;7:e39743. doi:10.1371/journal.pone.0039743. PMID:22761885
32. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015;6:6528. doi:10.1038/ncomms7528. PMID:25758642
33. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575-582. doi:10.1038/nrmicro2819. PMID:22728587